The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Gene expression profiling of human sarcomas: insights into sarcoma biology.
Published version of a preprint
Abstract
Sarcomas are a biologically complex group of tumors of mesenchymal origin. By using gene expression microarray analysis, we aimed to find clues into the cellular differentiation and oncogenic pathways active in these tumors as well as potential biomarkers and therapeutic targets. We examined 181 tumors representing 16 classes of human bone and soft tissue sarcomas on a 12,601-feature cDNA microarray. Remarkably, 2,766 probes differentially expressed across this sample set clearly delineated the various tumor classes. Several genes of potential biological and therapeutic interest were associated with each sarcoma type, including specific tyrosine kinases, transcription factors, and homeobox genes. We also identified subgroups of tumors within the liposarcomas, leiomyosarcomas, and malignant fibrous histiocytomas. We found significant gene ontology correlates for each tumor group and identified similarity to normal tissues by Gene Set Enrichment Analysis. Mutation analysis done on 275 tumor samples revealed that the high expression of epidermal growth factor receptor (EGFR) in certain tumors was not associated with gene mutations. Finally, to further the investigation of human sarcoma biology, we have created an online, publicly available, searchable database housing the data from the gene expression profiles of these tumors (http://watson.nhgri.nih.gov/sarcoma), allowing the user to interactively explore this data set in depth.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the overexpression of FGFRs in osteosarcoma cells13 has been associated with chemotherapy resistance.”
From Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma (2024) · cites this paper as [13]
Citations
Cites
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Summaries of Affymetrix GeneChip probe level data
Irizarry, R. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng015 · Cited by 4,887 · cited 2×
“All available samples were screened for mutations in KIT exons 9, 11, and 13, PDGFRA exons 12 and 18, and EGFR all exons ( 1-28 ).”
BackgroundMethodTissue microarrays for high-throughput molecular profiling of tumor specimens
Kononen, J., Bubendorf, L., Kallionimeni, A., Bärlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,099 · cited 2×
“All available samples were screened for mutations in KIT exons 9, 11, and 13, PDGFRA exons 12 and 18, and EGFR all exons ( 1-28 ).”
BackgroundMethodRosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475 · cited 2×
“All available samples were screened for mutations in KIT exons 9, 11, and 13, PDGFRA exons 12 and 18, and EGFR all exons ( 1-28 ).”
BackgroundMethodKhan, J., Wei, J. S., Ringnér, M., Saal, L. H., Ladanyi, M., Westermann, F., Berthold, F., Schwab, M., Antonescu, C. R., Peterson, C., et al. (2001) · Nature Medicine · doi:10.1038/89044 · Cited by 2,644
Self-citationJoensuu, H., Roberts, P. J., Sarlomo-Rikala, M., Andersson, L. C., Tervahartiala, P., Tuveson, D., Silberman, S. L., Capdeville, R., Dimitrijevic, S., Druker, B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441404 · Cited by 2,037 · cited 1×
“As exemplified by the success of imatinib in gastrointestinal stromal tumor, the receptor tyrosine kinases are attractive therapeutic targets ( 47 ) and there are currently clinical and preclinical trials evaluating various receptor tyrosine kinase inhibitors (48).”
BackgroundUse of a cDNA microarray to analyse gene expression patterns in human cancer
(1996) · Nature Genetics · doi:10.1038/ng1296-457 · Cited by 1,951
Cited by
Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics
Doyle, L. A., Vivero, M., Fletcher, C. D., Mertens, F., & Hornick, J. L. (2014) · Modern Pathology · doi:10.1038/modpathol.2013.164 · Cited by 795
Maki, R. G., Wathen, J. K., Patel, S. R., Priebat, D. A., Okuno, S. H., Samuels, B., Fanucchi, M., Harmon, D. C., Schuetze, S. M., Reinke, D., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.4117 · Cited by 742
Fibroblast growth factors and their receptors in cancer
Wesche, J., Haglund, K., & Haugsten, E. M. (2011) · Biochemical Journal · doi:10.1042/bj20101603 · Cited by 534
Chibon, F., Lagarde, P., Salas, S., Pérot, G., Brouste, V., Tirode, F., Lucchesi, C., de Reynies, A., Kauffmann, A., Bui, B., et al. (2010) · Nature Medicine · doi:10.1038/nm.2174 · Cited by 474
Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma
Smith, R., Owen, L. A., Trem, D. J., Wong, J. S., Whangbo, J. S., Golub, T. R., & Lessnick, S. L. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.004 · Cited by 351
“This has diagnostic and therapeutic implications for this important pediatric cancer.”
BackgroundMethodInfluential
Metadata
- Authors
- Baird, K., Davis, S., Antonescu, C. R., Harper, U. L., Walker, R. L., Chen, Y., Glatfelter, A. A., Duray, P. H., & Meltzer, P. S.
- Affiliations
- National Human Genome Research Institute (US)
- Memorial Sloan Kettering Cancer Center (US)
- National Institutes of Health (US)
- Venue
- Cancer Research
- Published
- 2005-10-15
- Volume
- 65
- Issue
- 20
- Pages
- 9226-9235
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2118471037
- Cited by
- 353
- References
- 57
- Citations by year
- 2025: 8 · 2024: 9 · 2023: 14 · 2022: 8 · 2021: 12 · 2020: 20 · 2019: 15 · 2018: 15 · 2017: 15 · 2016: 8 · 2015: 13 · 2014: 15 · 2013: 27 · 2012: 19
- FWCI
- 18.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- sarcoma, gene expression profiling, bone sarcoma, soft tissue sarcoma, tumor classification, liposarcoma, leiomyosarcoma, malignant fibrous histiocytoma, tyrosine kinase, transcription factors, homeobox genes, EGFR, somatic mutations, therapeutic target, biomarkers
- MeSH terms
- Genes, Homeobox, Humans, Leiomyosarcoma, Liposarcoma, Protein-Tyrosine Kinases, Sarcoma, Signal Transduction, Cluster Analysis, Gene Expression Profiling, Wnt Proteins, Histiocytoma, Malignant Fibrous
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gene expression profiling of human sarcomas: insights into sarcoma biology. https://app.cochat.ai/papers/10.1158/0008-5472.can-05-1699
- The paper
- Baird, K., Davis, S., Antonescu, C. R., Harper, U. L., Walker, R. L., Chen, Y., Glatfelter, A. A., Duray, P. H., & Meltzer, P. S. (2005). Gene expression profiling of human sarcomas: insights into sarcoma biology. Cancer Research. https://doi.org/10.1158/0008-5472.can-05-1699
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.